L. Daniel Browne
Overview
L. Daniel Browne received an average of $4M in total compensation, including $497K in salary, at Revance Therapeutics from 2013 to 2019.
2019Revance TherapeuticsFormer President and Chief Executive Officer
2018Revance TherapeuticsPresident and Chief Executive Officer
2017Revance TherapeuticsPresident and Chief Executive Officer
2016Revance TherapeuticsPresident and Chief Executive Officer
2015Revance TherapeuticsPresident and Chief Executive Officer
2014Revance TherapeuticsPresident and Chief Executive Officer
2013Revance TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on March 26, 2020, March 25, 2019, March 20, 2018, March 24, 2017, March 18, 2016, and March 26, 2015.
Related executives
We found 12 more executives who work or worked at Revance Therapeutics.
Mark Foley
Revance Therapeutics
Chief Executive Officer
Dustin Sjuts
Revance Therapeutics
President
Aubrey Rankin
Revance Therapeutics
Former President, Innovation & Technology
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
Dwight Moxie
Revance Therapeutics
General Counsel
Caryn McDowell
Revance Therapeutics
General Counsel
Todd Zavodnick
Revance Therapeutics